Login
Navigate Fool.com
Will MRK beat
the market?

Merck & Co., Inc.

NYSE: MRK

Community Rating: 4 Stars: Favorite

47.16 -0.17 (-0.36%)

REAL-TIME: Last trade at

Extended Hours: $46.83 -$0.33 (-0.71%)
Quote as of (NYSE)


company name or ticker

Recent Quotes

Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.05
Previous Close $47.33
Daily Range $46.60 - $47.16
52-Week Range $37.02 - $48.79
Market Cap $142.4B
P/E Ratio 24.15
Dividend (Yield) $1.72 (3.6%)
Ex-Dividend Date
Dividend Pay Date
03/13/13
04/05/13
Volume 15,629,085
Average Daily Volume 17,266,540
Current FY EPS $3.49

How do you think MRK
will perform against the market?

Top MRK Bull/Bear Pitches

 

alcear (< 20)
Submitted April 29, 2011

rotation into healthcare

0 Replies Reply Report this Post
 

nitraMcoD (3.53)
Submitted August 25, 2006

There are fundamental shifts occurring in the industry that will eat away at the efficiencies MRK currently enjoys. While their response to these shifts will be correct, their size will slow down thei … More

0 Replies Reply Report this Post

News & Commentary

Why Immunotherapy Stocks Could Be Set for a Big Move

The American Society of Clinical Oncology's annual meeting kicks off late next week, and this group of stocks looks primed to impress analysts and investors alike.

Merck Halts Parkinson's Drug Trials

The health care giant doesn’t obtain the desired results, opts to discontinue preladenant drug trials.

Unclear Future for Merck's Insomnia Drug

The FDA advisory committee has discussed Suvorexant; now shareholders need to get ready for the agency's final decision this summer.

Merck Discontinues Studies on Preladenant Drug

Merck Stock Is a Good Investment (According to Merck)

Merck accelerates its buyback.

Merck halts development of experimental Parkinson's drug

Merck Provides Update on Phase III Clinical Program for Preladenant, the Company’s Investigational P

Why Dow Jones Laggards Are Important Leading Indicators

New Stock Coverage: Can Johnson & Johnson Be Market's Band-Aid?

Wall Street ratings agencies set the tone for today's stock market.

Stocks Fall on Fear That Cheap Money May End Soon

Markets were flying high this morning until Ben Bernanke sent investors running.

See More MRK News...

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

Featured Broker Partners

Learn more about our new Fool ticker page!

Take a Tour
no thanks